Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3TC or FTC Monotherapy vs. Continuing HAART in Non-adherent HIV Youth
NCT01338025Phase 4Terminated
- Sponsor
- IMPAACT Network
- Start
- Mar 2011
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 4 trial of lamivudine, emtricitabine in human immunodeficiency virus infection (HIV), sponsored by IMPAACT Network. Started Mar 2011; status: terminated.
02
Drugs
lamivudineemtricitabine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01338025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01338025.